Although these early observations suggested a possible pathogenic role for Kir4.1 autoimmunity in both adult MS and pediatric ADD, later investigations failed to consistently replicate these findings, raising concerns about the specificity, reproducibility, and diagnostic value of anti-Kir4.1 antibodies [100,101,102]. The gene discussed is KCNJ10; the disease is myeloid sarcoma.